Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz Aesthetics US

Division of Merz GMBH & Co. KGAA
www.bioformmedical.com

Latest From Ligand Pharmaceuticals Inc.

Deals Shaping The Medical Industry, May 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in April 2017.

Deals BioPharmaceutical

Pipeline Watch: Phase III Progress With Abemaciclib, Esketamine

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

United will finance clinical development of drug/inhaler device combo with Respira. Takeda offloads more mature products to its joint venture with Teva, and signs a microbiome partnership with Finch Therapeutics.

Deals M & A

The Decline And Fall Of The Pharma Pipeline

2016 saw a drop in the growth rates for both number of products in active development and in the number of companies in active R&D. The data from a new report from Pharmaprojects seem to point to an end to recent years of accelerated growth in the pipeline that followed five years of stagnation.

Research & Development Analysis
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Radiofrequency Devices
  • Therapeutic Areas
  • Dermatology
  • Gynecological, Urological
  • Alias(es)
  • BioForm Medical Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merz GMBH & Co. KGAA
  • Senior Management
  • Steven L Basta, CEO
    Dale DeVore, VP, R&D
    Dennis Condon, Pres. & CBO
    Adam Gridley, SVP, Corp. Dev.
    Chris Holmes, VP, Sales
    Pat Altavilla, VP, Mktg.
  • Contact Info
  • Merz Aesthetics US
    Phone: (650) 286-4000
    1875 South Grant St., Ste. 110
    San Mateo, CA 94402
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register